
Gynaecologic Oncology in Akola: Cervical, Uterine and Ovarian Cancer
Gynaecologic oncology at Niramay Hospital, Akola, covers cancers of the cervix, uterus, ovaries, vagina and vulva. Dr. Shraddha Sor, Gynaecologic Oncologist [CONFIRM], provides consultation, screening guidance and treatment planning, working with the surgical, medical and radiation oncology team.
स्त्रीरोग कॅन्सर — गर्भाशयमुख, गर्भाशय आणि अंडाशय कॅन्सर सल्ला व उपचार नियोजन, अकोला.
Screening and prevention
Cervical cancer can often be found early, or prevented, through screening such as a Pap smear, an HPV test or visual inspection. [CONFIRM: EVA scanner screening, if offered.] HPV vaccination is recommended by health authorities for girls and young women, and you can discuss it with your doctor. Women with symptoms should not wait for a routine screening date.
Diagnosis usually involves a gynaecological examination, ultrasound, a biopsy or tissue sample, and CT or MRI scans for staging. Blood tests such as tumour markers may be used for some cancers.
Cancers we evaluate
Symptoms that need a check
Treatment options
Supportive care
Post-Treatment Care and Rehabilitation
Cancers of the cervix, ovary, uterus, vulva and vagina affect more than the body. They can change sexual health, fertility, bladder and bowel function and emotional wellbeing. Our follow-up care covers recovery in all of these areas.
Regular follow-up
Tests during follow-up
Pelvic floor and bladder care
Vaginal care after radiotherapy
Lymphoedema care
Menopausal symptoms
Sexual health and intimacy
Fertility and family planning
Genetic counselling
Nutrition, exercise and weight care
Emotional support
Prevention and screening for the family
See your doctor promptly if you notice: abnormal vaginal bleeding or discharge, new pelvic or back pain, leg swelling, a swollen abdomen, change in bladder or bowel habits, or unexplained weight loss.
Treatment Success and Survival Rates
| Cancer and group | 5-year survival | Source |
| Cervical cancer, all stages (11 Indian registries, 2012-2015) | About 52% | NCRP study |
| Cervical cancer, screened rural population, Maharashtra | About 60% overall; about 95% for stage IA | Barshi study |
| Cervical cancer, Tata Memorial Hospital (cases 2006-2008) | Stage I about 84%, II about 81%, III about 66%, IV about 37% | Tata Memorial study |
| Endometrial (uterine) cancer, USA | All stages about 81%; localized about 95%; regional about 70%; distant about 20% | Healthtree summary |
| Ovarian cancer, USA (2010-2016) | All stages about 49%; localized about 93%; regional about 75%; distant about 30% | SEER data, as reported |
Stage at diagnosis is the strongest factor
Early cervical cancer detected through screening has far better outcomes than advanced disease. The Maharashtra study credits early detection plus adequate treatment for its higher survival (Barshi study).
Ovarian cancer is often found late
because early symptoms are vague, which is why survival figures are lower overall.
Wide variation within India
published survival differs by region and by access to timely treatment (NCRP study).
Other factors
age, general health, tumour type and grade, and completeness of treatment all matter.
Limits of these numbers
they describe groups of patients treated in the past in different settings. Treatment keeps improving, so people diagnosed today may do better than older figures suggest.
What Happens During Your Visit

1. Consultation

2. Tests, if needed

3. Treatment planning


